Millrock Technology Welcomes Neil A. Goldman as Its New Chief Financial Officer
On April 22, 2026, Millrock Technology, a leading provider of lyophilization and advanced freeze-drying solutions specifically for the life sciences and biopharmaceutical industries, announced an important addition to its executive team. The company has appointed Neil A. Goldman, CPA, as its new Chief Financial Officer. Goldman comes with a wealth of experience, having a commendable background in both private equity-backed and public companies within sectors such as MedTech and advanced manufacturing. His expertise spans several high-profile roles that have notably influenced organizational growth and efficiency.
Goldman previously held the position of CFO at Life Science Outsourcing, Inc., where he played a crucial role in improving operational efficiencies and modernizing enterprise systems to facilitate growth. His impressive career also includes work at BioPorto A/S, a Copenhagen-listed in-vitro diagnostics firm, and other significant companies like Chembio Diagnostics and Unwired Technology. Goldman began his professional journey at Ernst & Young, and he earned a Bachelor of Science degree in Business from Miami University.
At Millrock Technology, Goldman is set to enhance the company’s financial infrastructure. His leadership will help steer strategic growth initiatives and support the organization’s plans for continuous expansion in the highly competitive market of freeze-drying technologies.
Tom Hochuli, CEO of Millrock Technology, expressed his enthusiasm about Goldman’s appointment, highlighting how his extensive experience in both public and private sectors, along with a proven ability to scale operations, aligns perfectly with Millrock's vision for future growth. Hochuli remarked, "Neil's leadership will be instrumental as we continue to build a world-class organization."
Goldman himself shared his excitement for this opportunity, stating, "I am eager to join Millrock Technology at such a crucial moment for the company and the lyophilization market. Millrock’s strong reputation for innovation, service, and high-quality products stands out, and I look forward to collaborating with the team to fast-track our strategic roadmap."
Millrock Technology is recognized as an innovator in developing freeze-drying (lyophilization) instruments and process development solutions tailored for the pharmaceutical, biotech, and diagnostics industries. They specialize in various scales of lyophilizers, featuring advanced process controls designed to enhance efficiency, compliance, and scalability. For more information, you can visit their website at www.millrocktech.com.
As the company aims to solidify its standing as a market leader, Neil A. Goldman’s appointment as CFO is a testament to Millrock Technology's commitment to excellence and growth. With his strategic leadership, the company is poised for an exciting future, fully equipped to make meaningful advancements in lyophilization technology.
Goldman previously held the position of CFO at Life Science Outsourcing, Inc., where he played a crucial role in improving operational efficiencies and modernizing enterprise systems to facilitate growth. His impressive career also includes work at BioPorto A/S, a Copenhagen-listed in-vitro diagnostics firm, and other significant companies like Chembio Diagnostics and Unwired Technology. Goldman began his professional journey at Ernst & Young, and he earned a Bachelor of Science degree in Business from Miami University.
At Millrock Technology, Goldman is set to enhance the company’s financial infrastructure. His leadership will help steer strategic growth initiatives and support the organization’s plans for continuous expansion in the highly competitive market of freeze-drying technologies.
Tom Hochuli, CEO of Millrock Technology, expressed his enthusiasm about Goldman’s appointment, highlighting how his extensive experience in both public and private sectors, along with a proven ability to scale operations, aligns perfectly with Millrock's vision for future growth. Hochuli remarked, "Neil's leadership will be instrumental as we continue to build a world-class organization."
Goldman himself shared his excitement for this opportunity, stating, "I am eager to join Millrock Technology at such a crucial moment for the company and the lyophilization market. Millrock’s strong reputation for innovation, service, and high-quality products stands out, and I look forward to collaborating with the team to fast-track our strategic roadmap."
Millrock Technology is recognized as an innovator in developing freeze-drying (lyophilization) instruments and process development solutions tailored for the pharmaceutical, biotech, and diagnostics industries. They specialize in various scales of lyophilizers, featuring advanced process controls designed to enhance efficiency, compliance, and scalability. For more information, you can visit their website at www.millrocktech.com.
As the company aims to solidify its standing as a market leader, Neil A. Goldman’s appointment as CFO is a testament to Millrock Technology's commitment to excellence and growth. With his strategic leadership, the company is poised for an exciting future, fully equipped to make meaningful advancements in lyophilization technology.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.